Acropetal Technologies Limited is an India-based company, which is focused on enterprise development, product development, software development and enterprise business services. The Company's segments include Engineering Design, Information Technology Service and Health Care. The Company is focused on the theme of innovation. It focuses on categories, such as education, healthcare, and manufacturing, consumer packaged goods (CPG) and retail. In education category, the Company is focused on digital learning, distance/mobile learning and educational applications. In healthcare category, the Company is focused on patient life cycle management, physician and clinical life cycle management, hospital administration management, drug discovery and administration management, and disease life cycle management. In manufacturing, CPG and retail category, the Company is focused on processes, such as research and development, global supply chain management exchange and new product development.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.